Logopenic Variant Primary Progressive Aphasia: Clinical Trials

4 trials for Logopenic Variant Primary Progressive Aphasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 3 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Completed 1
Early Phase 11Completed 1

Follow Logopenic Variant Primary Progressive Aphasia: new trials by email Literature Review of Logopenic Variant Primary Progressive Aphasia trials Research Report on Logopenic Variant Primary Progressive Aphasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Remotely-supervised Neuromodulation in PPA
Lexical Retrieval Cascade Treatment, Remotely Supervised Transcranial Direct Current Stimulation- Active, Remotely Supervised Transcranial Direct Current Stimulation - Sham - Primary Progressive Aphasia(PPA), Progressive Aphasia
Not applicableRecruitingMaya Henry802026-04-152026-09-04
Intervention for Communication Quality of Life in Primary Progressive Aphasia
Multicomponent Lexical Retrieval Cascade Training, Multicomponent Video Implemented Script Training in Aphasia - Primary Progressive Aphasia(PPA), Semantic Dementia
Not applicableRecruitingMaya Henry302026-04-012026-04-21
TMS for the Treatment of Primary Progressive Aphasia
Active rTMS, SHAM rTMS - Logopenic Variant Primary Progressive Aphasia, Non-fluent Variant Primary Progressive Aphasia
Not applicableCompletedMassachusetts General Hospital102022-03-012026-04-01
rTMS as a Treatment for PPA
Active rTMS, SHAM rTMS - Logopenic Variant Primary Progressive Aphasia, Non-Fluent Primary Progressive Aphasia
Early Phase 1CompletedMassachusetts General Hospital122019-12-012022-04-07

Narrower conditions

Aphasia (2)  ·  Aphasia, Primary Progressive (2)  ·  Primary Progressive Nonfluent Aphasia (2)  ·  Communication Disorders (1)  ·  Frontotemporal Dementia (1)  ·  Neurodegenerative Diseases (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Dementia (3)  ·  Language Disorders (3)  ·  Mental Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurocognitive Disorders (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Speech Disorders (3)  ·  Communication Disorders (2)  ·  Frontotemporal Lobar Degeneration (2)  ·  Metabolic Diseases (2)

Sponsors

Massachusetts General Hospital (2)  ·  Maya Henry (2)

Countries

United States (4)

Top investigators

Maya L Henry, PhD (2)  ·  Jessica D Richardson, PhD (1)  ·  Stephanie M Grasso, PhD (1)

NIH funding

K23DC016912 (1), RF1AG085565 (1)